4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-018047
Chief Medical Officer acquired 76,662 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| White Mark Andrew Chief Medical Officer | 2023-04-04 | Grant or award | +76,662 | 76,662 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| White Mark Andrew Chief Medical Officer | 2023-04-04 | Grant or award · Stock Option (Right to Buy) | +57,739 | 57,739 | D: show line 2 in the form |
Loading xslF345X04/form4.xml…